About this trial
This trial aims to investigate whether morning bright light therapy can reduce the progression rate of idiopathic scoliosis in children and potentially prevent its de novo development.
Eligibility criteria
Qualifiers
Age between 10 and 15 years.
Classified as evening chronotype based on the reduced Horne-Östberg Morningness-Eveningness Questionnaire (rMEQ), defined as a score < 12.
Has undergone radiographic evaluation (standing full-spine X-ray) for idiopathic scoliosis at the initial clinic visit.
Skeletally immature (Risser sign 0-3) with a major Cobb angle < 40 degrees at baseline.
Disqualifiers
Plans to relocate outside the study area within the next 24 months.
Use of medications that may interfere with circadian rhythm within the past 3 months (e.g., lithium, exogenous melatonin, melatonergic antidepressants).
Trans-meridian travel across at least two time zones within the past 3 months or anticipated during the study period.
Presence of any eye disease (e.g., glaucoma, retinal disease, macular degeneration) that could be exacerbated by or interfere with light therapy.
Trial design
Treatments tested in this trial
- Bright Light Therapy
- Sleep Hygiene Education
Treatment groups
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.